Association between sleep quality and C-reactive protein: Results from national health and nutrition examination survey, 2005-2008

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Liu, Rong ^a,b   Liu, Xin ^b   Zee, Phyllis C ^b   Hou, Lifang ^b   Zheng, Zheng ^c   Wei, Yongxiang ^a   Du, Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; MALE; NUTRITION; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SEX DIFFERENCE; SLEEP DISORDER; SLEEP QUALITY; UNITED STATES; VERY ELDERLY; HEALTH; INFORMATION PROCESSING; METABOLISM; MIDDLE AGED; SLEEP;

ADULT; C-REACTIVE PROTEIN; DATA COLLECTION; FEMALE; HEALTH; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; SLEEP; UNITED STATES;

EID: 84899766203     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092607     Document Type: Article

References (43)

1. Rifai N, Tracy RP, Ridker PM (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45: 2136-2141.
2. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, et al. (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321: 199-204. (Pubitemid 30459555)
3. Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103: 1813-1818.
4. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, et al. (1999) C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 100: 96-102. (Pubitemid 29297946)
5. Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165-2168.
6. Appels A, de Vos Y, van Diest R, Hoppner P, Mulder P, et al. (1987) Are sleep complaints predictive of future myocardial infarction? Act Nerv Super (Praha) 29: 147-151.
7. Schwartz SW, Cornoni-Huntley J, Cole SR, Hays JC, Blazer DG, et al. (1998) Are sleep complaints an independent risk factor for myocardial infarction? Ann Epidemiol 8: 384-392. (Pubitemid 28340539)
8. Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, et al. (2000) Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 48: 115-123. (Pubitemid 30106514)
9. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59: 131-136. (Pubitemid 34137380)
10. Vozoris NT (2012) Sleep apnea-plus: prevalence, risk factors, and association with cardiovascular diseases using United States population-level data. Sleep Med 13: 637-644.
11. Li Y, Walters AS, Chiuve SE, Rimm EB, Winkelman JW, et al. (2012) Prospective study of restless legs syndrome and coronary heart disease among women. Circulation 126: 1689-1694.
12. Ishida K, Kato M, Kato Y, Yanagihara K, Kinugasa Y, et al. (2009) Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest 136: 125-129.
13. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, et al. (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43: 678-683. (Pubitemid 38229544)
14. Taheri S, Austin D, Lin L, Nieto FJ, Young T, et al. (2007) Correlates of serum C-reactive protein (CRP)- -no association with sleep duration or sleep disordered breathing. Sleep 30: 991-996. (Pubitemid 47221899)
15. Trotti LM, Rye DB, De Staercke C, Hooper WC, Quyyumi A, et al. (2012) Elevated C-reactive protein is associated with severe periodic leg movements of sleep in patients with restless legs syndrome. Brain Behav Immun 26: 1239-1243.
16. Grandner MA, Buxton OM, Jackson N, Sands-Lincoln M, Pandey A, et al. (2013) Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep 36: 769-779.
17. Laugsand LE, Vatten LJ, Bjorngaard JH, Hveem K, Janszky I (2012) Insomnia and high-sensitivity C-reactive protein: the HUNT study, Norway. Psychosom Med 74: 543-553.
18. Miller MA, Kandala NB, Kivimaki M, Kumari M, Brunner EJ, et al. (2009) Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep 32: 857-864.
19. Matthews KA, Zheng H, Kravitz HM, Sowers M, Bromberger JT, et al. (2010) Are inflammatory and coagulation biomarkers related to sleep characteristics in mid-life women?: Study of Women's Health across the Nation sleep study. Sleep 33: 1649-1655.
20. Dowd JB, Goldman N, Weinstein M (2011) Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann Epidemiol 21: 799-806.
21. Jackowska M, Kumari M, Steptoe A (2013) Sleep and biomarkers in the English Longitudinal Study of Ageing: associations with C-reactive protein, fibrinogen, dehydroepiandrosterone sulfate and hemoglobin. Psychoneuroendocrinology 38: 1484-1493.
22. Bansil P, Kuklina EV, Merritt RK, Yoon PW (2011) Associations between sleep disorders, sleep duration, quality of sleep, and hypertension: results from the National Health and Nutrition Examination Survey, 2005 to 2008. J Clin Hypertens (Greenwich) 13: 739-743.
23. Albert MA, Ridker PM (2006) C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation 114: e67-74. (Pubitemid 44264805)
24. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Laboratory Protocol[2005-2006]. Available: http://www.cdc.gov/nchs/nhanes/ nhanes2005-2006/current-nhanes-05-06.htm. accessed Feb. 25th 2013.
25. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data[1999-2010]. Available: http://www.cdc.gov/nchs/data/nhanes/survey-content- 99-12.pdf. accessed Apr. 25th 2013.
26. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). National Center for Health Statistics (NCHS) National Center for Health Statistics Ethics Review Board. Available: http://www.cdc.gov/nchs/nhanes/irba98.htm. accessed Oct. 10th 2013.
27. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, et al. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511. (Pubitemid 36158056)
28. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). NHANES Analysis Course. Available: http://www.cdc.gov/nchs/tutorials/NHANES/NHANESAnalyses/NHANES-Analyses-intro. htm accessed Apr. 25th 2013.
29. Ford ES, Giles WH, Myers GL, Rifai N, Ridker PM, et al. (2003) C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem 49: 1353-1357. (Pubitemid 36900622)
30. Spiegel K (2008) Sleep loss as a risk factor for obesity and diabetes. Int J Pediatr Obes 3 Suppl 2: 27-28.
31. Dinges DF, Douglas SD, Zaugg L, Campbell DE, McMann JM, et al. (1994) Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest 93: 1930-1939. (Pubitemid 24143070)
32. Mollicone DJ, Van Dongen HP, Rogers NL, Dinges DF (2008) Response Surface Mapping of Neurobehavioral Performance: Testing the Feasibility of Split Sleep Schedules for Space Operations. Acta Astronaut 63: 833-840.
33. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, et al. (1999) Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84: 2603-2607. (Pubitemid 30641979)
34. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, et al. (2001) Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 107: 165-170. (Pubitemid 32105261)
35. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82: 4196-4200. (Pubitemid 27525539)
36. Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354: 1435-1439. (Pubitemid 29494756)
37. Spiegel K, Tasali E, Penev P, Van Cauter E (2004) Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141: 846-850. (Pubitemid 39601178)
38. Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, et al. (2004) The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 27: 661-666. (Pubitemid 38823362)
39. Agras WS, Hammer LD, McNicholas F, Kraemer HC (2004) Risk factors for childhood overweight: a prospective study from birth to 9.5 years. J Pediatr 145: 20-25. (Pubitemid 38962447)
40. Reilly JJ, Armstrong J, Dorosty AR, Emmett PM, Ness A, et al. (2005) Early life risk factors for obesity in childhood: cohort study. BMJ 330: 1357.
41. Patel SR, Malhotra A, White DP, Gottlieb DJ, Hu FB (2006) Association between reduced sleep and weight gain in women. Am J Epidemiol 164: 947-954. (Pubitemid 44729835)
42. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB (2005) Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 28: 1289-1296. (Pubitemid 41437890)
43. Plaisance EP, Grandjean PW (2006) Physical activity and high-sensitivity C-reactive protein. Sports Med 36: 443-458.